Biotech Values

[ghmm]

FOLD: Amicus is up ~30% I caught some of the presentation today and didn't hear anything that I thought merited that kind of move, maybe JC said something in a break out session .

Here is a nice (fluff) piece on Crowley/Amicus for anyone interested.

http://www.xconomy.com/new-york/2012/01/11/amicus-counts-on-chaperone-tech-to-enhance-rare-disease-treatments/